| Literature DB >> 33810142 |
Denise Dekker1,2, Frederik Pankok3, Thorsten Thye1, Stefan Taudien3, Kwabena Oppong4, Charity Wiafe Akenten4, Maike Lamshöft1,2, Anna Jaeger1, Martin Kaase3, Simone Scheithauer3, Konstantin Tanida5, Hagen Frickmann5,6, Jürgen May1,2,7, Ulrike Loderstädt3.
Abstract
Wound infections are common medical problems in sub-Saharan Africa but data on the molecular epidemiology are rare. Within this study we assessed the clonal lineages, resistance genes and virulence factors of Gram-negative bacteria isolated from Ghanaian patients with chronic wounds. From a previous study, 49 Pseudomonas aeruginosa, 21 Klebsiellapneumoniae complex members and 12 Escherichia coli were subjected to whole genome sequencing. Sequence analysis indicated high clonal diversity with only nine P. aeruginosa clusters comprising two strains each and one E. coli cluster comprising three strains with high phylogenetic relationship suggesting nosocomial transmission. Acquired beta-lactamase genes were observed in some isolates next to a broad spectrum of additional genetic resistance determinants. Phenotypical expression of extended-spectrum beta-lactamase activity in the Enterobacterales was associated with blaCTX-M-15 genes, which are frequent in Ghana. Frequently recorded virulence genes comprised genes related to invasion and iron-uptake in E. coli, genes related to adherence, iron-uptake, secretion systems and antiphagocytosis in P. aeruginosa and genes related to adherence, biofilm formation, immune evasion, iron-uptake and secretion systems in K. pneumonia complex. In summary, the study provides a piece in the puzzle of the molecular epidemiology of Gram-negative bacteria in chronic wounds in rural Ghana.Entities:
Keywords: Gram-negative bacteria; clonal lineages; colonization; infection; resistance genes; virulence factors; wounds
Year: 2021 PMID: 33810142 PMCID: PMC8004795 DOI: 10.3390/antibiotics10030339
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Minimum spanning tree of P. aeruginosa based on 3867 targets (core genome). Isolate numbers are found within the nodes, and numbers between nodes indicate the number of different alleles. Isolates within clusters are colored based on MLST sequence type (ST). The ST types of white nodes are indicated in Table A1.
Analysis of antimicrobial resistance determinants, ordered by strain and MLST type, of the assessed P. aeruginosa isolates. ST = Sequence type.
| Sample ID | ST-Type | Acquired Resistance Determinants Against | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta Lacatams | Sulfonamids | Fosfomycin | Trimethoprim | Makrolides | Tetracyclinws | Fluoroquinolones | Chloramphenicol | Rifampicin | Aminoglycosides | Efflux Pumps | Amino Acid Exchanges Due to Point Mutations | Disinfectant Resistance Genes | ||
| 017 | ST 381 |
|
|
| ||||||||||
| 022 | ST 2483 |
|
|
| ||||||||||
| 032 | ST 3587 |
|
|
|
|
|
| |||||||
| 069 | ST 360 |
|
|
| ||||||||||
| 081 | ST 244 |
|
|
| ||||||||||
| 082 | ST 514 |
|
|
| ||||||||||
| 088 | ST 1682 |
|
|
| ||||||||||
| 099 | ST 244 |
|
|
| ||||||||||
| 106 | ST 1521 |
|
|
| ||||||||||
| 114 | ST 244 |
|
| |||||||||||
| 137 | ST 3014 |
|
| |||||||||||
| 144 | ST 245 |
|
|
| ||||||||||
| 147 | ST 245 |
|
|
| ||||||||||
| 149 | ST 381 |
|
|
| ||||||||||
| 153 | ST 704 | |||||||||||||
| 154 | ST 244 |
|
|
| ||||||||||
| 157 | ST 2616 |
|
| |||||||||||
| 160 | ST 170 |
| ||||||||||||
| 162 | ST 274 |
|
|
| ||||||||||
| 180 | ST 856 |
|
|
| ||||||||||
| 183 | ST 244 |
|
| |||||||||||
| 186 | ST 3588 | |||||||||||||
| 190 | ST 871 |
|
| |||||||||||
| 195 | ST 988 |
| ||||||||||||
| 196 | ST 2475 |
|
|
| ||||||||||
| 198 | ST 2476 |
|
|
| ||||||||||
| 204 | ST 639 |
|
|
| ||||||||||
| 208 | ST 132 |
|
|
| ||||||||||
| 218 | ST 856 |
|
|
| ||||||||||
| 229 | ST 270 |
|
|
| ||||||||||
| 233 | ST 3227 |
|
|
| ||||||||||
| 236 | ST 266 |
|
|
| ||||||||||
| 238 | ST 3589 | |||||||||||||
| 242 | ST 3590 | |||||||||||||
| 243 | ST 3590 | |||||||||||||
| 272 | ST 2033 |
| ||||||||||||
| 274 | ST 2033 |
|
| |||||||||||
| 278 | ST 988 |
| ||||||||||||
| 282 | ST 554 |
|
|
| ||||||||||
| 285 | ST 554 |
|
|
| ||||||||||
| 289 | ST 1485 |
|
|
| ||||||||||
| 290 | ST 1485 |
|
|
| ||||||||||
| 296 | ST 235 |
|
|
| ||||||||||
| 298 | ST 3227 |
|
|
| ||||||||||
| 301 | ST 3593 | |||||||||||||
| 302 | ST 1755 |
|
|
| ||||||||||
| 309 | ST 3592 |
| ||||||||||||
| 310 | ST 532 |
|
|
| ||||||||||
| 312 | ST 381 |
|
|
| ||||||||||
Acquired resistance genes for macrolides, rifampicin, resistance-associated point mutations, genes for efflux pumps or genes mediating tolerance against disinfectants were not detected.
Analysis of antimicrobial resistance determinants, ordered by strain and MLST type, of the assessed K. pneumoniae isolates. ST = Sequence type.
| Sample ID | ST-Type | Acquired Resistance Determinants Against | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta Lacatams | Sulfonamids | Fosfomycin | Trimethoprim | Macrolides | Tetracyclines | Fluoroquinolones | Chloramphenicol | Rifampicin | Aminoglycosides | Efflux Pumps | Amino Acid Exchanges Due to Point Mutations | Disinfectant Resistance Genes * | ||
| 044 | ST 327 |
|
|
| ||||||||||
| 060 | ST 5379 |
|
|
|
|
|
|
|
| |||||
| 073 | ST 39 |
|
|
|
|
|
|
|
|
| ||||
| 100 | ST 152 |
|
|
|
|
|
|
|
|
|
| |||
| 102 | ST 514 |
|
|
|
|
| ||||||||
| 124 | ST 399 |
|
|
|
| |||||||||
| 146 | ST 4 |
|
|
|
|
| ||||||||
| 177 | ST 17 |
|
|
|
|
|
| |||||||
| 181 | ST 5380 |
|
|
| ||||||||||
| 184 | ST 5381 |
| ||||||||||||
| 199 | ST 17 |
|
|
|
|
| ||||||||
| 214 | ST 6 |
|
|
|
| |||||||||
| 217 | ST 3154 |
|
|
|
|
| ||||||||
| 220 | ST 5382 |
| ||||||||||||
| 234 | ST 109 |
| ||||||||||||
| 240 | ST 5383 |
| ||||||||||||
| 248 | ST 5384 |
|
| |||||||||||
| 252 | ST 607 |
|
|
|
|
|
| |||||||
| 267 | ST 36 |
|
|
|
|
|
|
|
| |||||
| 277 | ST 530 |
|
|
|
|
| ||||||||
| 279 | ST 5385 |
|
|
| ||||||||||
* qacE = quaternary ammonium compounds resistance and oqxB and oqxA = efflux pumps mediating resistance against disinfectants.
Figure 2Minimum spanning tree of K. pneumoniae complex based on 2358 targets (core genome). Isolate numbers are found within the nodes, and the numbers between the nodes indicate the number of different alleles. Colors demonstrate the MLST sequence type of the isolates.
Figure 3Minimum spanning tree of E. coli based on 2513 targets (core genome). Isolate numbers are found within the nodes, and the numbers between the nodes indicate the number of different alleles. Colors demonstrate the Pasteur sequence type of the isolates.
Analysis of antimicrobial resistance determinants, ordered by strain and MLST type, of the assessed E. coli isolates. ST = Sequence type.
| Sample ID | ST-Type | Acquired Resistance Determinants Against | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta lacatams | Sulfonamids | Trimethoprim | Makrodlids | Tetracyclins | Fluoroquinolones | Chloramphenicol | Aminoglycosides | Efflux pumps | Amino acid exchanges due to point mutations | Disinfectant resistance genes * | ||
| 041 | ST 2 |
|
|
|
|
|
|
|
| |||
| 049 | ST 3 |
|
|
|
|
|
|
| ||||
| 068 | ST 632 |
|
|
|
|
|
| |||||
| 117 | ST 4 |
|
|
|
|
|
| |||||
| 152 | ST 22 |
|
|
|
|
|
| |||||
| 176 | ST 132 |
|
|
|
|
|
|
| ||||
| 221 | ST 132 |
|
|
|
|
|
|
| ||||
| 222 | ST 132 |
|
|
|
|
|
|
| ||||
| 225 | ST 506 |
|
|
|
|
|
| |||||
| 245 | ST 2 |
|
|
|
|
|
|
|
|
|
| |
| 270 | ST 2 |
|
|
|
| |||||||
| 299 | ST 1018 |
|
|
|
|
|
| |||||
* sitABCD = peroxides resistance, qacE = quaternary ammonium compounds resistance.
Phenotypic resistance the P. aeruginosa strains. Data are missing for strains 198, 218 and 312, due to loss during subcultivation. MIC = minimum inhibitory concentration. N.a. = value missing due to loss of strain or failed reaction.
| Sample ID | Piperacillin | Piperacillin/Tazobactam | Ceftrazidime | Cefepime | Imipenem | Meropenem | Gentamicin | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | |
| 17 | ≤4 | S | ≤4 | S | ≤1 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S |
| 22 | ≤4 | S | ≤4 | S | ≤1 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S |
| 32 | ≤4 | S | 8 | S | 2 | S | 2 | S | 1 | S | ≤0.25 | S | ≤1 | S |
| 69 | ≤4 | S | ≤4 | S | 4 | S | 2 | S | 1 | S | ≤0.25 | S | ≤1 | S |
| 81 | ≤4 | S | 8 | S | 2 | S | ≤1 | S | 1 | S | 1 | S | ≤1 | S |
| 82 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 88 | ≥128 | R | ≥128 | R | ≥64 | R | 32 | R | ≥16 | R | 4 | I | ≤1 | S |
| 99 | 8 | S | 8 | S | 4 | S | 2 | S | 2 | S | 1 | S | ≤1 | S |
| 106 | ≤4 | S | 8 | S | 2 | S | 2 | S | 2 | S | 1 | S | ≤1 | S |
| 114 | ≤4 | S | 8 | S | 2 | S | ≤1 | S | 2 | S | 1 | S | ≤1 | S |
| 137 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | 2 | S | ≤1 | S |
| 144 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | 1 | S | ≤1 | S |
| 147 | 8 | S | ≤4 | S | 4 | S | 8 | S | 2 | S | 0.5 | S | 4 | S |
| 149 | 8 | S | 8 | S | 4 | S | 2 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S |
| 153 | ≤4 | S | 8 | S | 2 | S | ≤1 | S | 1 | S | ≤0.25 | S | ≤1 | S |
| 154 | 64 | R | ≤4 | S | ≤1 | S | ≤1 | S | 2 | S | 0.5 | S | ≤1 | S |
| 157 | 16 | S | 8 | S | 4 | S | 4 | S | 2 | S | ≤0.25 | S | 2 | S |
| 160 | ≥128 | R | 32 | R | 16 | R | 32 | R | 8 | I | 8 | I | 8 | R |
| 162 | 64 | R | 32 | R | 8 | S | 8 | S | 2 | S | 1 | S | 2 | S |
| 180 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 183 | 8 | S | 8 | S | 4 | S | 2 | S | 2 | S | 0.5 | S | ≤1 | S |
| 186 | 16 | n.a. | n.a. | S | 4 | S | 2 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 190 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | 0.5 | S | ≤1 | S |
| 195 | 8 | S | 8 | S | 4 | S | ≤1 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 196 | ≤4 | S | ≤4 | S | 2 | S | ≤1 | S | 2 | S | 0.5 | S | ≤1 | S |
| 198 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| 204 | 8 | S | 8 | S | 2 | S | ≤1 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 208 | 8 | S | 8 | S | 4 | S | 2 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 218 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| 229 | 8 | S | 8 | S | 4 | S | 2 | S | 1 | S | ≤0.25 | S | ≤1 | S |
| 233 | ≥128 | R | ≥128 | R | 32 | R | 8 | S | 8 | I | 4 | I | ≤1 | S |
| 236 | 16 | S | 16 | S | 4 | S | 2 | S | 2 | S | 0.5 | S | 2 | S |
| 238 | 8 | S | 16 | S | 4 | S | 2 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 242 | 8 | S | 8 | S | 4 | S | 2 | S | 1 | S | ≤0.25 | S | ≤1 | S |
| 243 | 16 | S | 8 | S | 4 | S | 2 | S | 1 | S | ≤0.25 | S | ≤1 | S |
| 272 | 64 | R | 64 | R | 8 | S | 4 | S | 2 | S | 1 | S | ≤1 | S |
| 274 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | 0.5 | S | ≤1 | S |
| 278 | ≤4 | S | ≤4 | S | 2 | S | ≤1 | S | 2 | S | ≤0.25 | S | ≤1 | S |
| 282 | ≤4 | S | 8 | S | ≤1 | S | ≤1 | S | 2 | S | 1 | S | ≤1 | S |
| 285 | ≤4 | S | ≤4 | S | ≤1 | S | ≤1 | S | 2 | S | 1 | S | ≤1 | S |
| 289 | ≤4 | S | 8 | S | ≤1 | S | ≤1 | S | 2 | S | 1 | S | ≤1 | S |
| 290 | 8 | S | 8 | S | ≤1 | S | ≤1 | S | 2 | S | 1 | S | ≤1 | S |
| 296 | ≥128 | R | 64 | R | 4 | S | 8 | S | 1 | S | 1 | S | ≥16 | R |
| 298 | ≥128 | R | ≥128 | R | ≥64 | R | 8 | S | 8 | I | 4 | I | ≤1 | S |
| 301 | 16 | S | 8 | S | 4 | S | 2 | S | 2 | S | 0.5 | S | ≤1 | S |
| 302 | 8 | S | 8 | S | 4 | S | ≤1 | S | 2 | S | 0.5 | S | ≤1 | S |
| 309 | 16 | S | 8 | S | 4 | S | 4 | S | 2 | S | 1 | S | ≤1 | S |
| 310 | 32 | R | 16 | S | 4 | S | 4 | S | 2 | S | 1 | S | ≤1 | S |
| 312 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
Phenotypic resistance of P. aeruginosa strains. Data are missing for strains 198, 218 and 312 due to loss during subcultivation. MIC = minimum inhibitory concentration. N.a. = value missing due to loss of strain or failed reaction.
| Sample ID | Ciprofloxacin | Moxifloxacin | Aztreonam | Amikacin | Tobramycin | Fosfomycin | Colistin | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | |
| 17 | ≤0.25 | S | 1 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 22 | ≤0.25 | S | 1 | R | 2 | I | ≤2 | S | ≤1 | S | 128 | R | 1 | S |
| 32 | ≤0.25 | S | 2 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 69 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 81 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 82 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 88 | 2 | R | ≥8 | R | 32 | R | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 99 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 106 | 2 | R | 1 | R | 8 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 114 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 137 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 144 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 147 | ≤0.25 | S | 2 | R | 4 | I | 8 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 149 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 153 | ≤0.25 | S | 2 | R | 4 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 154 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 157 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 160 | 1 | R | ≥8 | R | ≥64 | R | 16 | I | ≤1 | S | 64 | R | ≤0.5 | S |
| 162 | 0.5 | S | 2 | R | 32 | R | 4 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 180 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 183 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 186 | ≤0.25 | S | 1 | R | 16 | I | ≤2 | S | ≤1 | S | 32 | R | ≤0.5 | S |
| 190 | ≤0.25 | S | 1 | R | 16 | I | 4 | S | ≤1 | S | 32 | R | ≤0.5 | S |
| 195 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 64 | R | ≤0.5 | S |
| 196 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 64 | R | ≤0.5 | S |
| 198 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| 204 | ≤0.25 | S | 1 | R | 2 | I | ≤2 | S | ≤1 | S | 32 | R | 2 | S |
| 208 | ≤0.25 | S | 1 | R | 8 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 218 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| 229 | ≤0.25 | S | 1 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 233 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 236 | ≤0.25 | S | 1 | R | 16 | I | 8 | S | ≤1 | S | 64 | R | ≤0.5 | S |
| 238 | ≤0.25 | S | 2 | R | 8 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 242 | ≤0.25 | S | 1 | R | 8 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 243 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | 64 | R | ≤0.5 | S |
| 272 | ≤0.25 | S | 2 | R | 32 | R | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 274 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | ≥256 | R | ≤0.5 | S |
| 278 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 282 | ≤0.25 | S | 1 | R | 2 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 285 | ≤0.25 | S | 1 | R | 2 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 289 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 290 | ≤0.25 | S | 0.5 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 296 | ≥4 | R | ≥8 | R | 32 | R | ≤2 | S | ≥16 | R | 64 | R | ≤0.5 | S |
| 298 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 301 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 302 | ≤0.25 | S | 1 | R | 4 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 309 | ≤0.25 | S | 1 | R | 4 | I | ≤2 | S | ≤1 | S | ≤16 | R | ≤0.5 | S |
| 310 | ≤0.25 | S | 2 | R | 16 | I | ≤2 | S | ≤1 | S | 128 | R | ≤0.5 | S |
| 312 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
Phenotypic resistance of the Klebsiella strains. MIC = minimum inhibitory concentration. ESBL = signal in phenotypic testing for extended-spectrum beta-lactamases.
| Sample ID | ESBL | Ampicillin | Ampicillin/Sulbactam | Piperacillin/Tazobactam | Cefuroxime | Cefuroxime Axetil | Cefpodoxime | Cefotaxime | Ceftrazidime | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | ||
| 44 | negative | ≥32 | R | 16 | R | ≤4 | S | 4 | I | 4 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 60 | negative | ≥32 | R | 16 | R | ≤4 | S | ≤1 | I | ≤1 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 73 | positive | ≥32 | R | ≥32 | R | ≥128 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 8 | R |
| 100 | positive | ≥32 | R | ≥32 | R | ≥128 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
| 102 | negative | ≥32 | R | ≤2 | I | 8 | S | 8 | I | 8 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 124 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 146 | negative | ≥32 | R | ≤2 | I | 8 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 177 | positive | ≥32 | R | ≥32 | R | ≥128 | R | 2 | I | 2 | S | ≤0.25 | S | ≤1 | S | ≤1 | I |
| 181 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 184 | negative | 16 | R | ≤2 | I | ≤4 | S | 2 | I | 2 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 199 | positive | ≥32 | R | ≥32 | R | 8 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
| 214 | negative | ≥32 | R | ≤2 | I | ≤4 | S | ≤1 | I | ≤1 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 217 | negative | ≥32 | R | ≥32 | R | ≥128 | R | 4 | I | 4 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 220 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 4 | I | 4 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 234 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 240 | negative | ≥32 | R | ≤2 | I | ≤4 | S | ≤1 | I | ≤1 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 248 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 252 | negative | ≥32 | R | 16 | R | ≤4 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 267 | positive | ≥32 | R | ≥32 | R | 32 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
| 277 | negative | ≥32 | R | ≥32 | R | 64 | R | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 279 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 2 | I | 2 | I | ≤0.25 | S | ≤1 | S | ≤1 | S |
Phenotypic resistance of the Klebsiella strains. MIC = minimum inhibitory concentration. ESBL = signal in phenotypic testing for extended-spectrum beta-lactamases.
| Sample ID | ESBL | Ertapenem | Imipenem | Meropenem | Gentamicin | Ciprofloxacin | Moxifloxacin | Tigecycline | Trimethoprim/Sulfamethoxazole | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | ||
| 44 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≤20 | S |
| 60 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | 1 | R | 2 | R | ≤0.5 | S | ≥320 | R |
| 73 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | 1 | R | 2 | R | ≤0.5 | S | ≥320 | R |
| 100 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
| 102 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | 0.5 | R | 4 | R | ≤20 | S |
| 124 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≤20 | S |
| 146 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | 1 | S | ≤20 | S |
| 177 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | 2 | I | ≥320 | R |
| 181 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≤20 | S |
| 184 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≤20 | S |
| 199 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 214 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 217 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | ≤0.25 | S | ≤0.25 | S | 2 | I | ≥320 | R |
| 220 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | 0.5 | R | 1 | S | ≤20 | S |
| 234 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | 0.5 | R | 1 | S | ≤20 | S |
| 240 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≤20 | S |
| 248 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | 2 | I | ≤20 | S |
| 252 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | 1 | S | ≥320 | R |
| 267 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 277 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | 1 | S | ≥320 | R |
| 279 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≤20 | S |
Phenotypic resistance of Escherichia coli strains. MIC = minimum inhibitory concentration. ESBL = signal in phenotypic testing for extended-spectrum beta-lactamases.
| Sample ID | ESBL | Ampicillin | Ampicillin/Sulbactam | Piperacillin/Tazobactam | Cefuroxime | Cefuroxime Axetil | Cefpodoxime | Cefotaxime | Ceftrazidime | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | ||
| 41 | positive | ≥32 | R | ≥32 | R | 64 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
| 49 | negative | ≥32 | R | 16 | R | ≤4 | S | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 68 | negative | ≥32 | R | 16 | R | ≤4 | S | ≤1 | I | ≤1 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 117 | negative | ≥32 | R | ≥32 | R | 64 | R | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 152 | negative | ≥32 | R | ≥32 | R | ≥128 | R | 4 | I | 4 | S | 0.5 | S | ≤1 | S | ≤1 | S |
| 176 | negative | ≥32 | R | ≥32 | R | ≤4 | I | 2 | I | 2 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 221 | negative | ≥32 | R | ≥32 | R | ≤4 | I | 2 | I | 2 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 222 | negative | ≥32 | R | ≥32 | R | ≤4 | I | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
| 225 | positive | ≥32 | R | ≥32 | R | ≤4 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
| 245 | positive | ≥32 | R | ≥32 | R | 16 | I | 16 | R | 16 | R | 1 | S | 2 | I | ≤1 | S |
| 270 | positive | ≥32 | R | 16 | R | ≤4 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | ≥64 | R |
| 299 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
Phenotypic resistance of Escherichia coli strains. MIC = minimum inhibitory concentration. ESBL = signal in phenotypic testing for extended-spectrum beta-lactamases.
| Sample ID | ESBL | Ertapenem | Imipenem | Meropenem | Gentamicin | Ciprofloxacin | Moxifloxacin | Tigecycline | Trimethoprim/Sulfamethoxazole | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | ||
| 41 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
| 49 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 68 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
| 117 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 152 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | 2 | S | 1 | R | 2 | R | ≤0.5 | S | ≥320 | R |
| 176 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 221 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 222 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
| 225 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | 0.5 | I | 1 | R | ≤0.5 | S | ≥320 | R |
| 245 | positive | ≤0.5 | S | 0.5 | S | ≤0.25 | S | ≥16 | R | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
| 270 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≥4 | R | ≥8 | R | ≤0.5 | S | ≤20 | S |
| 299 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | 0.5 | I | 2 | R | ≤0.5 | S | ≥320 | R |
Figure A1Clustal omega multiple alignment of oprD proteins—one example for the 7 detected subgroups.
Analysis of virulence determinants, ordered by strain and MLST type, of the assessed E. coli isolates. ST = Sequence type.
| Sample ID | ST-Type | Pathogenicity Factor Groups | |||||
|---|---|---|---|---|---|---|---|
| Adherence | Invasion | Toxin | Immune Evasion | Iron Uptake | Protease | ||
| 041 | ST 2 |
| |||||
| 049 | ST 3 | chuS, chuU, chuV, chuW, chuY, | |||||
| 068 | ST 632 |
| |||||
| 117 | ST 4 |
|
| chuA, chuS, chuT, chuU, chuV, chuW, chuX, chuY, |
| ||
| 152 | ST 22 |
|
|
|
|
| |
| 176 | ST 132 |
|
| ||||
| 221 | ST 132 |
| |||||
| 222 | ST 132 |
|
| ||||
| 225 | ST 506 |
| |||||
| 245 | ST 2 |
|
| ||||
| 270 | ST 2 |
|
| ||||
| 299 | ST 1018 |
| |||||
Analysis of virulence determinants, ordered by strain and MLST type, of the assessed P. aeruginosa isolates. ST = Sequence type.
| Sample ID | ST-Type | Pathogenicity Factor Groups | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Adherence | Anti-Phagocytosis | Biosurfactant | Iron Uptake | Pigment | Protease | Toxin | Regulation | Secretion System | ||
| 017 | ST 381 |
|
|
|
|
|
|
|
|
|
| 022 | ST 2483 |
|
|
|
|
|
|
|
|
|
| 032 | ST 3587 |
|
|
|
|
|
|
|
|
|
| 069 | ST 360 |
|
|
|
|
|
|
|
|
|
| 081 | ST 244 |
|
|
|
|
|
|
|
|
|
| 082 | ST 514 |
|
|
|
|
|
|
|
|
|
| 088 | ST 1682 |
|
|
|
|
|
|
|
|
|
| 099 | ST 244 |
|
|
|
|
|
|
|
|
|
| 106 | ST 1521 |
|
|
|
|
|
|
|
|
|
| 114 | ST 244 |
|
|
|
|
|
|
|
|
|
| 137 | ST 3014 |
|
|
|
|
|
|
|
|
|
| 144 | ST 245 |
|
|
|
|
|
|
|
|
|
| 147 | ST 245 |
|
|
|
|
|
|
|
|
|
| 149 | ST 381 |
|
|
|
|
|
|
|
|
|
| 153 | ST 704 |
|
|
|
|
|
|
|
|
|
| 154 | ST 244 |
|
|
|
|
|
|
|
|
|
| 157 | ST 2616 |
|
|
|
|
|
|
|
|
|
| 160 | ST 170 |
|
|
|
|
|
|
|
|
|
| 162 | ST 274 |
|
|
|
|
|
|
|
|
|
| 180 | ST 856 |
|
|
|
|
|
|
|
|
|
| 183 | ST 244 |
|
|
|
|
|
|
|
|
|
| 186 | ST 3588 |
|
|
|
|
|
|
|
|
|
| 190 | ST 871 |
|
|
|
|
|
|
|
|
|
| 195 | ST 988 |
|
|
|
|
|
|
|
|
|
| 196 | ST 2475 |
|
|
|
|
|
|
|
|
|
| 198 | ST 2476 |
|
|
|
|
|
|
|
|
|
| 204 | ST 639 |
|
|
|
|
|
|
|
|
|
| 208 | ST 132 |
|
|
|
|
|
|
|
|
|
| 218 | ST 856 |
|
|
|
|
|
|
|
|
|
| 229 | ST 270 |
|
|
|
|
|
|
|
|
|
| 233 | ST 3227 |
|
|
|
|
|
|
|
|
|
| 236 | ST 266 |
|
|
|
|
|
|
|
|
|
| 238 | ST 3589 |
|
|
|
|
|
|
|
|
|
| 242 | ST 3590 |
|
|
|
|
|
|
|
|
|
| 243 | ST 3590 |
|
|
|
|
|
|
|
|
|
| 272 | ST 2033 |
|
|
|
|
|
|
|
|
|
| 274 | ST 2033 |
|
|
|
|
|
|
|
|
|
| 278 | ST 988 |
|
|
|
|
|
|
|
|
|
| 282 | ST 554 |
|
|
|
|
|
|
|
|
|
| 285 | ST 554 |
|
|
|
|
|
|
|
|
|
| 289 | ST 1485 |
|
|
|
|
|
|
|
|
|
| 290 | ST 1485 |
|
|
|
|
|
|
|
|
|
| 296 | ST 235 |
|
|
|
|
|
|
|
|
|
| 298 | ST 3227 |
|
|
|
|
|
|
|
|
|
| 301 | ST 3593 |
|
|
|
|
|
|
|
|
|
| 302 | ST 1755 |
|
|
|
|
|
|
|
|
|
| 309 | ST 3592 |
|
|
|
|
|
|
|
|
|
| 310 | ST 532 |
|
|
|
|
|
|
|
|
|
| 312 | ST 381 |
|
|
|
|
|
|
|
|
|
Analysis of virulence determinants, ordered by strain and MLST type, of the assessed K. pneumoniae isolates. ST = Sequence type.
| Sample ID | ST-Type | Pathogenicity Factor Groups | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adherence | Biofilm Formation | Efflux Pump | Immune Evasion | Iron Uptake | Nutritional Factor | Regulation | Secretion System | Serum Resistance | Toxin | ||
| 044 | ST 327 |
|
|
|
|
|
|
|
| ||
| 060 | ST 5379 |
|
|
|
|
|
|
| |||
| 073 | ST 39 |
|
|
|
|
|
|
|
| ||
| 100 | ST 152 |
|
|
|
|
|
|
| |||
| 102 | ST 514 |
|
|
|
|
|
|
|
| ||
| 124 | ST 399 |
|
|
|
|
|
|
| |||
| 146 | ST 4 |
|
|
|
|
|
|
|
| ||
| 177 | ST 17 |
|
|
|
|
|
|
|
| ||
| 181 | ST 5380 |
|
|
|
|
|
|
|
| ||
| 184 | ST 5381 |
|
|
|
|
|
|
| |||
| 199 | ST 17 |
|
|
|
|
|
|
| |||
| 214 | ST 6 |
|
|
|
|
|
|
|
| ||
| 217 | ST 3154 |
|
|
|
|
|
|
|
| ||
| 220 | ST 5382 |
|
|
|
|
|
|
| |||
| 234 | ST 109 |
|
|
|
|
|
|
|
| ||
| 240 | ST 5383 |
|
|
|
|
|
|
| |||
| 248 | ST 5384 |
|
|
|
|
|
|
| |||
| 252 | ST 607 |
|
|
|
|
|
|
|
| ||
| 267 | ST 36 |
|
|
|
|
|
|
|
| ||
| 277 | ST 530 |
|
|
|
|
|
|
|
| ||
| 279 | ST 5385 |
|
|
|
|
|
|
|
| ||
Details on the strain-specific short-read archive (SRA) accession numbers.
| Sample ID | Percentage of Good Targets (SeqSphere+) | Average Coverage (Assembled) (SeqSphere+) | Approximated Genome Size (Megabases) (SeqSphere+) | Species (Kraken2) | Sequence Type | Complex Type (SeqSphere+) | SRA Accession |
|---|---|---|---|---|---|---|---|
| Iso00017 | 99.4 | 105 | 6.7 |
| 381 | 1791 | SRR13617317 |
| Iso00022 | 99.4 | 102 | 6.9 |
| 2483 | 1792 | SRR13617316 |
| Iso00032 | 99.2 | 106 | 6.6 |
| 3587 | 1793 | SRR13617305 |
| Iso00041 | 99.4 | 97 | 5.0 |
| 2 (Pasteur) | 11349 | SRR13617294 |
| Iso00044 | 99.7 | 116 | 5.1 |
| 327 | 5462 | SRR13617283 |
| Iso00049 | 98.7 | 94 | 5.2 |
| 3 (Pasteur) | 11350 | SRR13617272 |
| Iso00060 | 99.6 | 112 | 5.3 |
| 5379 | 5463 | SRR13617261 |
| Iso00068 | 99.6 | 109 | 4.9 |
| 632 (Pasteur) | 11351 | SRR13617250 |
| Iso00069 | 99.6 | 104 | 6.8 |
| 360 | 1794 | SRR13617239 |
| Iso00073 | 99.4 | 104 | 5.8 |
| 39 | 5464 | SRR13617236 |
| Iso00081 | 98.7 | 108 | 6.6 |
| 244 | 1795 | SRR13617315 |
| Iso00082 | 99.4 | 112 | 6.3 |
| 514 | 1796 | SRR13617314 |
| Iso00088 | 97.8 | 105 | 6.8 |
| 1682 | 1797 | SRR13617313 |
| Iso00099 | 99.4 | 106 | 6.6 |
| 244 | 1798 | SRR13617312 |
| Iso00100 | 99.2 | 108 | 5.5 |
| 152 | 5465 | SRR13617311 |
| Iso00102 | 99.2 | 111 | 5.4 |
| 514 | 5466 | SRR13617310 |
| Iso00106 | 99.5 | 110 | 6.4 |
| 1521 | 1799 | SRR13617309 |
| Iso00114 | 99.4 | 105 | 6.7 |
| 244 | 1800 | SRR13617308 |
| Iso00117 | 99.2 | 95 | 5.3 |
| 4 (Pasteur) | 11352 | SRR13617307 |
| Iso00124 | 99.4 | 112 | 5.3 |
| 399 | 5467 | SRR13617306 |
| Iso00137 | 99.4 | 110 | 6.4 |
| 3014 | 1801 | SRR13617304 |
| Iso00144 | 99.6 | 109 | 6.5 |
| 245 | 1802 | SRR13617303 |
| Iso00146 | 99.4 | 110 | 5.5 |
| 4 | 5468 | SRR13617302 |
| Iso00147 | 99.5 | 108 | 6.6 |
| 245 | 1802 | SRR13617301 |
| Iso00149 | 99.6 | 104 | 6.9 |
| 381 | 1803 | SRR13617300 |
| Iso00152 | 99.4 | 98 | 5.2 |
| 22 (Pasteur) | 11353 | SRR13617299 |
| Iso00153 | 98.5 | 111 | 6.4 |
| 704 | ? | SRR13617298 |
| Iso00154 | 99.4 | 102 | 7.0 |
| 244 | 1805 | SRR13617297 |
| Iso00157 | 99.6 | 114 | 6.3 |
| 2616 | 1806 | SRR13617296 |
| Iso00160 | 99.2 | 115 | 6.2 |
| 170 | 1807 | SRR13617295 |
| Iso00162 | 99.1 | 111 | 6.5 |
| 274 | 1808 | SRR13617293 |
| Iso00176 | 99.0 | 98 | 5.1 |
| 132 (Pasteur) | 11354 | SRR13617292 |
| Iso00177 | 99.6 | 108 | 5.5 |
| 17 | 5469 | SRR13617291 |
| Iso00180 | 99.8 | 110 | 6.5 |
| 856 | 1809 | SRR13617290 |
| Iso00181 | 99.9 | 107 | 5.6 |
| 5380 | 5470 | SRR13617289 |
| Iso00183 | 99.5 | 107 | 6.7 |
| 244 | 1795 | SRR13617288 |
| Iso00184 | 98.3 | 104 | 5.6 | 5381 | 5471 | SRR13617287 | |
| Iso00186 | 98.7 | 113 | 6.3 |
| 3588 | 1810 | SRR13617286 |
| Iso00190 | 99.7 | 114 | 6.3 |
| 871 | 1811 | SRR13617285 |
| Iso00195 | 99.5 | 111 | 6.5 |
| 988 | 1812 | SRR13617284 |
| Iso00196 | 99.5 | 101 | 7.1 |
| 2475 | 1813 | SRR13617282 |
| Iso00198 | 99.6 | 112 | 6.4 |
| 2476 | 1814 | SRR13617281 |
| Iso00199 | 99.4 | 108 | 5.6 |
| 17 | 5472 | SRR13617280 |
| Iso00204 | 99.5 | 104 | 6.9 |
| 639 | 1815 | SRR13617279 |
| Iso00208 | 99.7 | 109 | 6.5 |
| 132 | 1816 | SRR13617278 |
| Iso00214 | 99.7 | 108 | 5.5 |
| 6 | 5473 | SRR13617277 |
| Iso00217 | 99.8 | 104 | 5.7 |
| 3154 | 5474 | SRR13617276 |
| Iso00218 | 99.7 | 109 | 6.5 |
| 856 | 1809 | SRR13617275 |
| Iso00220 | 97.8 | 110 | 5.4 | 5382 | 5475 | SRR13617274 | |
| Iso00221 | 99.0 | 94 | 5.1 |
| 132 (Pasteur) | 11354 | SRR13617273 |
| Iso00222 | 99.0 | 96 | 5.1 |
| 132 (Pasteur) | 11354 | SRR13617271 |
| Iso00225 | 99.1 | 99 | 5.2 |
| 506 (Pasteur) | 11355 | SRR13617270 |
| Iso00229 | 99.6 | 109 | 6.5 |
| 270 | 1817 | SRR13617269 |
| Iso00233 | 97.8 | 114 | 6.1 |
| 3227 | 1818 | SRR13617268 |
| Iso00234 | 99.7 | 111 | 5.5 |
| 109 | 5476 | SRR13617267 |
| Iso00236 | 99.7 | 112 | 6.4 |
| 266 | 1819 | SRR13617266 |
| Iso00238 | 98.7 | 108 | 6.6 |
| 3589 | 1820 | SRR13617265 |
| Iso00240 | 98.9 | 112 | 5.4 |
| 5383 | 5477 | SRR13617264 |
| Iso00242 | 98.9 | 111 | 6.4 |
| 3590 | 1821 | SRR13617263 |
| Iso00243 | 98.9 | 111 | 6.4 |
| 3590 | 1821 | SRR13617262 |
| Iso00245 | 99.3 | 107 | 4.8 |
| 2 (Pasteur) | 11356 | SRR13617260 |
| Iso00248 | 97.2 | 108 | 5.5 |
| 5384 | 5478 | SRR13617259 |
| Iso00252 | 99.6 | 112 | 5.3 |
| 607 | 5479 | SRR13617258 |
| Iso00267 | 99.6 | 103 | 5.7 |
| 36 | 5480 | SRR13617257 |
| Iso00270 | 99.2 | 100 | 4.9 |
| 2 (Pasteur) | 11358 | SRR13617256 |
| Iso00272 | 99.5 | 109 | 6.5 |
| 2033 | 1822 | SRR13617255 |
| Iso00274 | 99.4 | 109 | 6.5 |
| 2033 | 1822 | SRR13617254 |
| Iso00277 | 99.4 | 109 | 5.5 |
| 530 | 5481 | SRR13617253 |
| Iso00278 | 99.6 | 110 | 6.5 |
| 988 | 1823 | SRR13617252 |
| Iso00279 | 99.7 | 111 | 5.5 |
| 5385 | 5482 | SRR13617251 |
| Iso00282 | 99.3 | 108 | 6.6 |
| 554 | 1824 | SRR13617249 |
| Iso00285 | 99.3 | 109 | 6.5 |
| 554 | 1824 | SRR13617248 |
| Iso00289 | 99.6 | 112 | 6.3 |
| 1485 | 1825 | SRR13617247 |
| Iso00290 | 99.7 | 113 | 6.3 |
| 1485 | 1825 | SRR13617246 |
| Iso00296 | 99.7 | 106 | 6.7 |
| 235 | 1826 | SRR13617245 |
| Iso00298 | 97.8 | 116 | 6.1 |
| 3227 | 1818 | SRR13617244 |
| Iso00299 | 99.3 | 108 | 4.6 |
| 1018 (Pasteur) | 11357 | SRR13617243 |
| Iso00301 | 98.6 | 112 | 6.3 |
| 3593 | 1827 | SRR13617242 |
| Iso00302 | 99.6 | 113 | 6.3 |
| 1755 | 1828 | SRR13617241 |
| Iso00309 | 98.6 | 109 | 6.5 |
| 3592 | 1829 | SRR13617240 |
| Iso00310 | 99.3 | 105 | 6.8 |
| 532 | 1830 | SRR13617238 |
| Iso00312 | 99.4 | 106 | 6.7 |
| 381 | 1791 | SRR13617237 |